Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15
Recall Number: D-1058-2017
Firm: Teva Pharmaceuticals USA
Classification: Class III
Status: Terminated
Report Date: 20170816
Initiation Date: 20170802
Termination Date: 20180228
Reason for Recall
Failed Moisture Limits: out of specification test results for water content obtained during stability testing.
Product Description
Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15